Madronich Sasha, Lee-Taylor Julia M, Wagner Mark, Kyle Jessica, Hu Zeyu, Landolfi Robert
National Center for Atmospheric Research, Boulder, Colorado 80307, United States.
ICF, Arlington, Virginia 22202, United States.
ACS Earth Space Chem. 2021 Aug 10;5(8). doi: 10.1021/acsearthspacechem.1c00183.
Overexposure to ultraviolet (UV) radiation is a threat to human health. It can cause skin cancer and cataracts. Human-made ozone-depleting substances (ODSs) reduce the ozone concentration in the Earth's stratosphere, which acts as a protective shield from UV radiation. To protect and restore the ozone layer, the Montreal Protocol on Substances that Deplete the Ozone Layer was enacted in 1987 to phase out the production and consumption of certain ODSs and was later amended and adjusted to significantly strengthen its requirements. The United States Environmental Protection Agency (EPA) uses its Atmospheric and Health Effects Framework (AHEF) model to assess the adverse human health effects associated with stratospheric ozone depletion and the U.S. health benefits from the global implementation of the Montreal Protocol. Comparing the Montreal Protocol as amended and adjusted with a scenario of no controls on ODSs showed the prevention of an estimated 443 million cases of skin cancer and 63 million cataract cases for people born in the United States between 1890 and 2100. In addition, 2.3 million skin cancer deaths are avoided. Compared with the original 1987 Montreal Protocol, strengthening the Montreal Protocol, through its subsequent amendments and adjustments, resulted in an estimated 230 million fewer skin cancer cases, 1.3 million fewer skin cancer deaths, and 33 million fewer cataract cases.
过度暴露于紫外线辐射对人类健康构成威胁。它会导致皮肤癌和白内障。人为的消耗臭氧层物质会降低地球平流层中的臭氧浓度,而平流层臭氧起到阻挡紫外线辐射的保护屏障作用。为了保护和恢复臭氧层,1987年制定了《关于消耗臭氧层物质的蒙特利尔议定书》,以逐步淘汰某些消耗臭氧层物质的生产和消费,该议定书后来经过修订和调整,大幅强化了要求。美国环境保护局(EPA)使用其大气与健康影响框架(AHEF)模型来评估与平流层臭氧消耗相关的对人类健康的不利影响,以及全球实施《蒙特利尔议定书》给美国带来的健康益处。将经过修订和调整的《蒙特利尔议定书》与不对消耗臭氧层物质进行管控的情景进行比较表明,对于1890年至2100年间在美国出生的人,预计可预防4.43亿例皮肤癌和6300万例白内障病例。此外,可避免230万例皮肤癌死亡。与1987年最初的《蒙特利尔议定书》相比,通过后续的修订和调整强化该议定书,估计可减少2.3亿例皮肤癌病例、130万例皮肤癌死亡以及3300万例白内障病例。